These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

838 related articles for article (PubMed ID: 8215724)

  • 21. Efficacy of atorvastatin in achieving National Cholesterol Education Program low-density lipoprotein targets in women with severe dyslipidemia and cardiovascular disease or risk factors for cardiovascular disease: The Women's Atorvastatin Trial on Cholesterol (WATCH).
    McPherson R; Angus C; Murray P; Genest J;
    Am Heart J; 2001 Jun; 141(6):949-56. PubMed ID: 11376309
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of pravastatin on coronary events in 2073 patients with low levels of both low-density lipoprotein cholesterol and high-density lipoprotein cholesterol: results from the LIPID study.
    Colquhoun D; Keech A; Hunt D; Marschner I; Simes J; Glasziou P; White H; Barter P; Tonkin A;
    Eur Heart J; 2004 May; 25(9):771-7. PubMed ID: 15120888
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relation of plasma lipoprotein levels with low-grade inflammation in white men without clinical evidence of myocardial ischemia.
    Rivera JJ; Nasir K; Campbell C; Carvalho JA; Blumenthal RS; Santos RD
    Am J Cardiol; 2007 Aug; 100(3):450-4. PubMed ID: 17659927
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relation of clinical benefit of raising high-density lipoprotein cholesterol to serum levels of low-density lipoprotein cholesterol in patients with coronary heart disease (from the Bezafibrate Infarction Prevention Trial).
    Goldenberg I; Benderly M; Sidi R; Boyko V; Tenenbaum A; Tanne D; Behar S
    Am J Cardiol; 2009 Jan; 103(1):41-5. PubMed ID: 19101227
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Usefulness of childhood low-density lipoprotein cholesterol level in predicting adult dyslipidemia and other cardiovascular risks. The Bogalusa Heart Study.
    Bao W; Srinivasan SR; Wattigney WA; Bao W; Berenson GS
    Arch Intern Med; 1996 Jun; 156(12):1315-20. PubMed ID: 8651840
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Associations of postmenopausal hormone therapy with markers of hemostasis and inflammation and lipid profiles in diabetic and nondiabetic american Indian women: the strong heart study.
    Zhang Y; Howard BV; Cowan LD; Welty TK; Schaefer CF; Wild RA; Yeh J; Lee ET
    J Womens Health (Larchmt); 2004 Mar; 13(2):155-63. PubMed ID: 15072729
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low- and high-density lipoprotein cholesterol goal attainment in dyslipidemic women: The Lipid Treatment Assessment Project (L-TAP) 2.
    Santos RD; Waters DD; Tarasenko L; Messig M; Jukema JW; Ferrières J; Verdejo J; Chiang CW;
    Am Heart J; 2009 Nov; 158(5):860-6. PubMed ID: 19853709
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endogenous androgen levels and cardiovascular risk profile in women across the adult life span.
    Bell RJ; Davison SL; Papalia MA; McKenzie DP; Davis SR
    Menopause; 2007; 14(4):630-8. PubMed ID: 17224854
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiovascular events with increased lipoprotein-associated phospholipase A(2) and low high-density lipoprotein-cholesterol: the Veterans Affairs HDL Intervention Trial.
    Robins SJ; Collins D; Nelson JJ; Bloomfield HE; Asztalos BF
    Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1172-8. PubMed ID: 18356553
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-density vs low-density lipoprotein cholesterol as the risk factor for coronary artery disease and stroke in old age.
    Weverling-Rijnsburger AW; Jonkers IJ; van Exel E; Gussekloo J; Westendorp RG
    Arch Intern Med; 2003 Jul; 163(13):1549-54. PubMed ID: 12860577
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cardiovascular disease-related serum lipid parameters in a Hungarian subpopulation].
    Szépvölgyi J; Kravják BE; Bíró L; Nagy K; Bíró G; Antal M
    Orv Hetil; 1997 Aug; 138(32):2005-8. PubMed ID: 9297170
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multivariate assessment of lipid parameters as predictors of coronary heart disease among postmenopausal women: potential implications for clinical guidelines.
    Shai I; Rimm EB; Hankinson SE; Curhan G; Manson JE; Rifai N; Stampfer MJ; Ma J
    Circulation; 2004 Nov; 110(18):2824-30. PubMed ID: 15492318
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Smoking habits and lipoproteins in British women.
    Razay G; Heaton KW
    QJM; 1995 Jul; 88(7):503-8. PubMed ID: 7633876
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Eberbach/Wiesloch Study: lipoprotein profiles of 35- to 49-year-old men and women.
    Augustin J; Haberbosch W; Buchholz L; Grulich-Henn J; Kostner G; Morgenstern W; Nüssel E; Schettler G
    Klin Wochenschr; 1988; 66 Suppl 11():50-7. PubMed ID: 3184780
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ability of physical activity to predict cardiovascular disease beyond commonly evaluated cardiometabolic risk factors.
    McGuire KA; Janssen I; Ross R
    Am J Cardiol; 2009 Dec; 104(11):1522-6. PubMed ID: 19932786
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Study of the prevalence of hypercholesterolemia in Extremadura].
    Gimeno Ortiz A; Jiménez Romano R; Vázquez Domínguez JA; Rueda Muñoz C
    Rev Sanid Hig Publica (Madr); 1993; 67(4):267-78. PubMed ID: 7732293
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma lipids and lipoproteins and the prevalence of risk for coronary heart disease in Canadian adults. Canadian Heart Health Surveys Research Group.
    Connelly PW; MacLean DR; Horlick L; O'Connor B; Petrasovits A; Little JA
    CMAJ; 1992 Jun; 146(11):1977-87. PubMed ID: 1596847
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Women, lipoproteins and cardiovascular disease risk.
    LaRosa JC
    Can J Cardiol; 1990 May; 6 Suppl B():23B-29B. PubMed ID: 2188715
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of change in high-density lipoprotein cholesterol from baseline on risk for major cardiovascular events.
    Laitinen DL; Manthena S
    Adv Ther; 2010 Apr; 27(4):233-44. PubMed ID: 20437214
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality.
    Cui Y; Blumenthal RS; Flaws JA; Whiteman MK; Langenberg P; Bachorik PS; Bush TL
    Arch Intern Med; 2001 Jun; 161(11):1413-9. PubMed ID: 11386890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 42.